Peptides as Potential Therapeutics for Alzheimer’s Disease

By Ribarič Samo  

Molecules, Vol. 23, Iss. 2, 2018-01 ,pp. : 283-283

MDPI

Access to resources Recommend Favorite

Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer’s Disease Agents Using Pharmacophore, 3D-QSAR and Molecular Docking Approaches

By Pang Xiaocong   Fu Hui   Yang Shilun   Wang Lin   Liu Ai-Lin   Wu Song   Du Guan-Hua  

Molecules, Vol. 22, Iss. 8, 2017-07 ,pp. : 1254-1254

MDPI

Access to resources Recommend Favorite

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy

By Boulebd Houssem   Ismaili Lhassane   Bartolini Manuela   Bouraiou Abdelmalek   Andrisano Vincenza   Martin Helene   Bonet Alexandre   Moraleda Ignacio   Iriepa Isabel   Chioua Mourad   Belfaitah Ali   Marco-Contelles José  

Molecules, Vol. 21, Iss. 4, 2016-03 ,pp. : 400-400

MDPI

Access to resources Recommend Favorite

Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer’s Disease

By Cacciatore Ivana   Marinelli Lisa   Fornasari Erika   Cerasa Laura S.   Eusepi Piera   Türkez Hasan   Pomilio Cristina   Reale Marcella   D’Angelo Chiara   Costantini Erica   Di Stefano Antonio  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 1035-1035

MDPI

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease

By Dgachi Youssef   Bautista-Aguilera Oscar M.   Benchekroun Mohamed   Martin Hélène   Bonet Alexandre   Knez Damijan   Godyń Justyna   Malawska Barbara   Gobec Stanislav   Chioua Mourad   Janockova Jana   Soukup Ondrej   Chabchoub Fakher   Marco-Contelles José   Ismaili Lhassane  

Molecules, Vol. 21, Iss. 5, 2016-05 ,pp. : 634-634

MDPI

Access to resources Recommend Favorite